GlaxoSmithKline Pharmaceuticals Limited (BOM:500660)
India · Delayed Price · Currency is INR 2,601.00
+7.95 (0.31%)
At close: Aug 10, 2026
BOM:500660 Financials Overview
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Revenue Revenue Growth | 39,549 | 38,217 | 37,492 | 34,537 | 32,517 | 32,780 |
Revenue Growth | 5.75% | 1.93% | 8.56% | 6.21% | -0.80% | 12.05% |
Gross Profit Gross Profit Growth | 25,391 | 24,461 | 23,354 | 20,985 | 19,476 | 18,998 |
Operating Income Operating Income Growth | 12,915 | 12,476 | 11,143 | 8,390 | 7,484 | 6,988 |
Net Income Net Income Growth | 10,682 | 10,360 | 9,276 | 5,900 | 6,107 | 16,947 |
Earnings Per Share EPS Growth | 63.05 | 61.15 | 54.76 | 34.83 | 36.05 | 100.04 |
EPS Growth | 12.40% | 11.69% | 57.23% | -3.39% | -63.97% | 373.19% |
| Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
India India Growth | 37,696 | 36,987 | 33,923 | 31,877 | 31,961 |
Foreign Foreign Growth | 520.95 | 504.66 | 614.05 | 640.05 | 818.97 |
Total Total Growth | 38,217 | 37,492 | 34,537 | 32,517 | 32,780 |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Investments Cash & Investments Growth | 27,568 | 27,568 | 24,981 | 18,568 | 16,541 | 28,309 |
Total Debt Total Debt Growth | 332.72 | 332.72 | 99.51 | 186.65 | 155.39 | 200.77 |
Net Cash (Debt) Net Cash Growth | 27,235 | 27,235 | 24,882 | 18,382 | 16,386 | 28,108 |
Net Cash Growth | 9.46% | 9.46% | 35.36% | 12.18% | -41.70% | 154.93% |
Net Cash Per Share Net Cash Per Share Growth | 160.77 | 160.77 | 146.88 | 108.51 | 96.73 | 165.92 |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Cash Flow Operating Cash Flow Growth | - | 9,033 | 12,899 | 5,820 | 4,842 | 8,107 |
Capital Expenditures CapEx Growth | - | -552.79 | -230.22 | -312.22 | -440.39 | -346.41 |
Free Cash Flow Free Cash Flow Growth | - | 8,480 | 12,669 | 5,508 | 4,402 | 7,761 |
Free Cash Flow Growth | - | -33.06% | 130.01% | 25.13% | -43.28% | 45.42% |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Gross Margin | 64.20% | 64.00% | 62.29% | 60.76% | 59.89% | 57.96% |
Operating Margin | 32.66% | 32.65% | 29.72% | 24.29% | 23.02% | 21.32% |
Pretax Margin | 36.65% | 36.79% | 33.60% | 23.63% | 25.72% | 23.77% |
Profit Margin | 27.01% | 27.11% | 24.74% | 17.08% | 18.78% | 51.70% |
FCF Margin | - | 22.19% | 33.79% | 15.95% | 13.54% | 23.68% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 11, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Dividend Per Share Dividend Per Share Growth | 57.000 | 57.000 | 42.000 | 32.000 | 32.000 | 30.000 |
Dividend Per Share Growth | 5.56% | 35.71% | 31.25% | 0% | 6.67% | 0% |
Dividend Yield | 2.19% | 2.56% | 1.52% | 1.74% | 2.61% | 2.07% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 11, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 41.25 | 37.34 | 52.55 | 55.80 | 36.73 | 16.62 |
Forward PE | 36.58 | 34.16 | 49.88 | 44.16 | 35.58 | 42.30 |
P/FCF Ratio | 51.96 | 45.62 | 38.48 | 59.76 | 50.96 | 36.30 |
PS Ratio | 11.14 | 10.12 | 13.00 | 9.53 | 6.90 | 8.59 |